Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Non-cash Items for 5 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items changed N/A to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a N/A change, with the full-year FY2025 number at $1.5 million, changed N/A from a year prior.
  • Non-cash Items was $1.5 million for Q4 2025 at Relay Therapeutics, down from $9.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $45.9 million in Q4 2021 to a low of $1.5 million in Q4 2025.
  • A 4-year average of $23.0 million and a median of $22.2 million in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: decreased 24.54% in 2022, then plummeted 71.69% in 2023.
  • Relay Therapeutics' Non-cash Items stood at $45.9 million in 2021, then fell by 24.54% to $34.6 million in 2022, then tumbled by 71.69% to $9.8 million in 2023, then crashed by 84.94% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for RLAY's Non-cash Items are $1.5 million (Q4 2025), $9.8 million (Q4 2023), and $34.6 million (Q4 2022).